Drug Trial Radar · NCT02713893
Tolerability and Pharmacokinetic Study of Econazole Nitrate and Benzydamine HCl Intravaginal Cream
Last checked: Nov 19, 2026Latest source record: Jan 17, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Sep 2015
Primary completion
Jun 2016
Study completion Jun 15, 2016
Sponsor
- Lead sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.AIndustry
- Sponsor type
- Industry
- Collaborators
- Cross Research S.A.
- First posted
- Mar 21, 2016
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- Who can join
- Female only, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate local tolerability of the new Econazole/Benzydamine product, in comparison with the Econazole and Benzydamine stand-alone products and placebo. Pharmacokinetics of the study products after single and repeated applications once a day for 15 days, safety of the investigational products and comfort of use will also be evaluated as secondary objectives.
Conditions
- Healthy
Interventions
Econazole nitrate 1% plus Benzydamine HCl 0.12% intravaginal creamDrug
Placebo plus Econazole nitrate 1% intravaginal creamDrug
Placebo plus Benzydamine HCl 0.12% intravaginal creamDrug
Placebo intravaginal creamDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Local Adverse Events (AEs)Time frame: Up to 7 days after administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CROSS Research S.A., Phase I Unit
Arzo, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.